GRANT BURSELL: Open Payments
NPI 1104273648 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$963 in 14 payments from 5 companies in 2025. Trend: 2023 $17 · 2024 $735 · 2025 $963
Food & beverage: $963
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $500 |
| Lilly USA, LLC | 4 | $216 |
| Regeneron Healthcare Solutions, Inc. | 2 | $140 |
| Janssen Scientific Affairs, LLC | 2 | $70 |
| Ferring Pharmaceuticals Inc. | 2 | $37 |
Products named: TREMFYA, OMVOH, DUPIXENT, REBYOTA.
Industry payments across WA — which companies pay providers there.
